Symbol
| PEG10
| contributors: mct/pgu - updated : 21-02-2012
|
HGNC name
| paternally expressed 10
|
HGNC id
| 14005
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in a great majority of hepatocellular carcinomas | tumoral
|  
|  
| --over
|  
|
from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia BCLL | constitutional
|  
|  
| --low
|  
|
in third trimester downregulated in fetal samples group | |
Variant & Polymorphism
|
| |
Candidate gene
| represents a novel marker in B-CLL |
|
for the treatment of hepatocellular carcinomas(development of drug(s) inhibiting PEG10 activity could be a novel approach) |
Marker
| positive expression of PEG10 or TSG101 is a predictor of poor prognosis in gallbladder adenocarcinoma |
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | digestive | liver | |
for the treatment of hepatocellular carcinomas(development of drug(s) inhibiting PEG10 activity could be a novel approach) |
| |